• Aucun résultat trouvé

What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report

N/A
N/A
Protected

Academic year: 2021

Partager "What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report"

Copied!
8
0
0

Texte intégral

Références

Documents relatifs

Main causes of mismatch between workplace demands and functional capacities were manual handling of loads, postures with arms away from the body and repetitive motions at work;

Objective: We performed a cohort study in seven hospitals in Spain to determine the clinical characteristics of incident patients with bladder cancer, the diagnostic process, and

Acute pain: A quarter of respondents use gabapentinoids in all types of surgery (whatever the expected postoperative pain) and even more used them in ambulatory

Another issue, as suggested by the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO), is the lack of regulation resulting in

The literature demonstrates that buprenorphine is effective for longer-term opioid maintenance, although methadone remains a slightly superior substitution treatment..

For all these reasons, new formulations of extended- release buprenorphine (XR-BUP) have recently been developed and commercialized, offering a one-week, one- month,

This first French study in which patients on short DHD were compared with matched patients on thrice-weekly HD shows that patients on DHD have a lower chance of access

The most popular questionnaires are the Multiple Sclerosis Quality of Life questionnaire (MSQOL54) [15], the Functional Assessment of Multiple Sclerosis questionnaire (FAMS) [16],